genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
Leukocyte disorders
News
Peptide May Rejuvenate Immune Response, Combat Inflammaging
News
Novel Bone Marrow Failure Syndrome Treatment Discovered
Drug Discovery
Supreme Court’s Sandoz–Amgen Decision Boosts Biosimilars
Industry News
ProMetic to Acquire Telesta Therapeutics
Drug Discovery
FDA Approves First Biosimilar, Sandoz’s Zarxio™
Insights
Learning from the First Biosimilar Application
News
Amgen Buys Roche Rights to Neutropenia Drugs
Cancer
Mathematical Model Predicts Infection Risk in Chemotherapy Patients
Cancer
FDA Clears First New G-CSF Neutropenia Therapy in 10 Years
Drug Discovery
G-Zero Awarded $3.6M to Advance Pharmacoquiescence Approach to Radiomitigation
1
2
Page 1 of 2
Scroll Up
Scroll Up
